Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck’s Strong Q2 Overshadowed By Gardasil Sales Decline In China
Revenue Guidance Raised, EPS Expectation Lowered
Jul 30 2024
•
By
Mandy Jackson
Merck expects up to $64.4bn in full-year 2024 sales • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip